Conversely, for CAPEOX, single-agent 5-Fluorouracil, and single-agent Cetuximab, although a trend towards poorer efficacy in the HER2(1+) group was observed, this difference did not reach statistical significance within our study’s sample size ( P > 0.05).
← all excerpts
Patient-derived organoids reveal marked heterogeneity in chemosensitivity profiles of colorectal cancer and a potential association with HER2 status.
1
0.0500
0.0500